MEDNAX Inc

Market Summary

USD9.23-0.11

Market Closed

-1.18%

MD Stock Price

View Fullscreen

MD RSI Chart

MD Valuation

Market Cap

774.7M

Price/Earnings (Trailing)

8.28

Price/Sales (Trailing)

0.39

EV/EBITDA

Price/Free Cashflow

4.65

MD Price/Sales (Trailing)

MD Profitability

EBT Margin

6.58%

Return on Equity

11.18%

Return on Assets

4.38%

Free Cashflow Yield

21.53%

MD Fundamentals

MD Revenue

Revenue (TTM)

2.0B

Revenue Y/Y

3.41%

Revenue Q/Q

1.21%

MD Earnings

Earnings (TTM)

93.5M

Earnings Y/Y

-30.39%

Earnings Q/Q

-24.37%

Price Action

Last 7 days

11.3%

Last 30 days

-5.7%

Last 90 days

-26.7%

Trailing 12 Months

-40.4%

How does MD drawdown profile look like?

MD Financial Health

Current Ratio

1.44

MD Investor Care

Shares Dilution (1Y)

1.11%

Diluted EPS (TTM)

1.13

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	2.0B	2.0B	2.0B	0
2022	1.9B	2.0B	2.0B	2.0B
2021	1.7B	1.8B	1.8B	1.9B
2020	1.8B	1.8B	1.8B	1.7B
2019	3.0B	2.6B	2.2B	1.8B
2018	3.5B	3.5B	3.5B	3.5B
2017	3.3B	3.3B	3.4B	3.5B
2016	2.9B	3.0B	3.1B	3.2B
2015	2.5B	2.6B	2.7B	2.8B
2014	2.2B	2.3B	2.4B	2.4B
2013	1.9B	2.0B	2.1B	2.2B
2012	1.6B	1.7B	1.8B	1.8B
2011	1.5B	1.5B	1.6B	1.6B
2010	1.3B	1.3B	1.4B	1.4B
2009	1.1B	1.2B	1.2B	1.3B
2008	0	0	0	1.1B

Get all data in R, Python etc through our Historical Stock Data APIs

Latest Insider Trading transactions for MD

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Jun 14, 2023	swift james d	sold	-186,549	14.14	-13,193	chief executive officer
Jun 07, 2023	pickert curtis	gifted	-	-	-1,166	evp, chief operating officer
Jun 01, 2023	wood lee	sold (taxes)	-5,413	13.3	-407	evp, natl & market operations
Jun 01, 2023	pickert curtis	sold (taxes)	-5,000	13.3	-376	evp, chief operating officer
May 25, 2023	ordan mark s	sold	-437,580	13.26	-33,000	-
May 19, 2023	weis shirley a	sold	-13,725	13.63	-1,007	-
May 18, 2023	weis shirley a	sold	-243,805	13.55	-17,993	-
May 15, 2023	pickert curtis	gifted	-	-	-5,984	evp, chief operating officer
May 12, 2023	young sylvia jean	acquired	-	-	10,831	-
May 11, 2023	weis shirley a	acquired	-	-	10,965	-

Which funds bought or sold MD recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Dec 06, 2023	CITIGROUP INC	reduced	-41.11	-546,757	608,530	-%
Nov 24, 2023	DEUTSCHE BANK AG\	added	8.97	-13,426	517,246	-%
Nov 22, 2023	KBC Group NV	unchanged	-	-	97,000	-%
Nov 22, 2023	Public Sector Pension Investment Board	reduced	-30.21	-782,628	1,299,890	0.01%
Nov 21, 2023	COMERICA BANK	new	-	616,944	616,944	-%
Nov 17, 2023	JACOBS LEVY EQUITY MANAGEMENT, INC	reduced	-10.1	-560,346	2,299,660	0.01%
Nov 15, 2023	CAPTRUST FINANCIAL ADVISORS	new	-	197,831	197,831	-%
Nov 15, 2023	MANUFACTURERS LIFE INSURANCE COMPANY, THE	added	24.82	56,375	540,353	-%
Nov 15, 2023	PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO	added	1.91	-4,000	45,000	-%
Nov 15, 2023	JANE STREET GROUP, LLC	sold off	-100	-740,099	-	-%

Latest Funds Activity

Are funds buying MD calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own MD

No. of Funds

Schedule 13G FIlings of MEDNAX Inc

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
May 10, 2023	alliancebernstein l.p.	10.0%	8,392,304	SC 13G/A
Feb 14, 2023	alliancebernstein l.p.	7.8%	6,468,122	SC 13G/A
Feb 14, 2023	earnest partners llc	7.9%	6,546,580	SC 13G/A
Feb 09, 2023	fmr llc	-	0	SC 13G/A
Feb 09, 2023	vanguard group inc	11.72%	9,738,017	SC 13G/A
Jan 23, 2023	blackrock inc.	16.5%	13,672,143	SC 13G/A
Jan 20, 2023	starboard value lp	4.0%	3,348,578	SC 13D/A
Dec 02, 2022	starboard value lp	7.1%	5,915,000	SC 13D/A
Feb 14, 2022	arrowmark colorado holdings llc	3.10%	2,683,879	SC 13G/A
Feb 14, 2022	alliancebernstein l.p.	8.5%	7,359,083	SC 13G/A

Recent SEC filings of MEDNAX Inc

View All Filings

Date Filed	Form Type	Document
Nov 02, 2023	8-K	Current Report
Nov 02, 2023	10-Q	Quarterly Report

MD Fair Value

Peers (Alternatives to MEDNAX Inc)

View All Peers In Detail

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	508.7B	360.0B	1.94%	1.34%	23.46	1.41	14.24%	11.62%
CVS	96.7B	347.8B	5.35%	-27.64%	11.1	0.28	10.34%	159.11%
CI	91.1B	189.9B	-12.60%	-22.05%	13.64	1.92	5.24%	22.27%
HCA	69.2B	63.2B	8.96%	6.67%	12.11	1.1	5.62%	6.32%
CNC	39.4B	150.1B	3.44%	-15.03%	16.13	0.26	6.04%	21.35%
MID-CAP
DVA	9.8B	11.9B	32.01%	41.29%	16.13	0.82	2.36%	-10.41%
UHS	9.6B	14.0B	3.25%	4.87%	14.25	0.69	6.03%	-8.61%
CHE	8.6B	2.2B	-1.50%	10.15%	35.34	3.88	4.50%	-6.69%
ACHC	6.7B	2.9B	-3.11%	-12.16%	-365.93	2.34	13.16%	-106.47%
AMN	2.6B	4.1B	9.38%	-42.09%	9.25	0.63	-25.26%	-41.25%
SMALL-CAP
AMEH	1.6B	1.3B	13.24%	13.97%	34.86	1.17	27.06%	-27.04%
ADUS	1.5B	1.0B	6.69%	-15.76%	25.78	1.44	10.84%	30.19%
BKD	1.0B	3.0B	18.37%	74.00%	-8.11	0.34	6.98%	58.07%
BEAT	35.8M	-	2.22%	-73.51%	-2.47	-	-	-27.68%
AMS	15.8M	20.7M	7.02%	-13.27%	54.39	0.76	6.53%	-78.75%

MEDNAX Inc News

Latest updates

Nasdaq • 30 Nov 2023 • 08:00 am • 8 days ago

UBS Initiates Coverage of Pediatrix Medical Group (MD) with ...

Business Wire • 18 May 2023 • 07:00 am • 6 months ago

Concerned Shareholders of Cano Health Nominate Highly Qualified ...

DLA Piper • 26 Dec 2022 • 04:42 pm • 11 months ago

Michael Slovak

Business Wire • 21 Jun 2022 • 07:00 am • 17 months ago

Mednax To Change Name to Pediatrix Medical Group, Inc. Effective ...

StreetInsider.com • 12 Apr 2022 • 07:00 am • 20 months ago

Form 13F-HR/A EATON VANCE MANAGEMENT For: Dec 31

Nasdaq • 11 Mar 2022 • 08:00 am • 21 months ago

Anthem (ANTM) to be Renamed as Elevance Health for Rebranding

Business Wire • 17 Feb 2022 • 08:00 am • 21 months ago

Mednax Reports Fourth Quarter Results

Nasdaq • 07 Feb 2022 • 08:00 am • 22 months ago

Mednax (MD) Buys Night Lite Pediatrics to Boost Portfolio

Yahoo Finance • 07 Feb 2022 • 08:00 am • 22 months ago

Mednax (MD) Buys Night Lite Pediatrics to Boost Portfolio

PR Newswire • 07 Oct 2021 • 07:00 am • 2 years ago

Brave Care, The Leader in Technology-Powered Pediatric Clinics ...

StreetInsider.com • 20 Aug 2021 • 07:00 am • 2 years ago

Form N-PX Legg Mason ETF Investmen For: Jun 30

Yahoo Finance • 16 Jul 2021 • 07:00 am • 2 years ago

Down 11.6% in 4 Weeks, Here's Why Mednax (MD) Looks Ripe for a ...

Yahoo Finance • 17 Jun 2021 • 07:00 am • 2 years ago

Tenet Healthcare (THC) to Divest Hospitals for $1.1 Billion

ThinkMarkets • 15 Jun 2021 • 04:37 pm • 2 years ago

Our Contract Specifications - Get Trading

TMS Brokers • 13 May 2021 • 04:04 pm • 2 years ago

Akcje Boeing Co: Aktualny kurs - Bezpieczny Dom Maklerski TMS ...

Financials for MEDNAX Inc

Income Statement (Last 12 Months)
(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Revenue	1.2%	507	501	491	514	490	486	482	499	493	473	447	417	461	415	441	459	455	439	427	888	849
Operating Expenses	3.2%	466	452	461	478	443	436	443	431	434	423	421	384	440	381	430	418	406	396	387	783	745
S&GA Expenses	-1.0%	57.00	58.00	59.00	51.00	58.00	61.00	61.00	59.00	67.00	71.00	67.00	55.00	66.00	60.00	67.00	59.00	63.00	63.00	59.00	106	96.00
EBITDA Margin	-	-	-	0.10*	0.08*	0.10*	0.10*	0.10*	0.12*	0.11*	0.10*	0.09*	0.09*	0.09*	-0.70*	-0.69*	-0.53*	-	-	-	-	-
Interest Expenses	-7.6%	10.00	11.00	10.00	10.00	10.00	8.00	12.00	17.00	18.00	17.00	18.00	27.00	27.00	28.00	28.00	28.00	30.00	31.00	30.00	25.00	22.00
Income Taxes	-11.5%	9.00	11.00	7.00	4.00	10.00	12.00	-7.40	13.00	12.00	7.00	-4.95	6.00	7.00	3.00	1.00	4.00	7.00	7.00	-1.51	22.00	24.00
Earnings Before Taxes	-20.8%	31.00	39.00	21.00	28.00	39.00	43.00	-28.35	54.00	43.00	38.00	0.00	10.00	4.00	10.00	-17.41	14.00	20.00	13.00	11.00	83.00	86.00
EBT Margin	-	-	-	0.07*	0.04*	0.05*	0.06*	0.05*	0.07*	0.05*	0.03*	0.01*	0.00*	0.01*	-0.78*	-0.77*	-0.59*	-	-	-	-	-
Net Income	-24.4%	21.00	28.00	14.00	30.00	31.00	27.00	-21.19	48.00	31.00	35.00	18.00	-64.30	-41.04	-672	-18.71	9.00	-1,255	-8.24	-242	60.00	66.00
Net Income Margin	-	-	-	0.05*	0.03*	0.04*	0.04*	0.05*	0.07*	0.01*	-0.03*	-0.44*	-0.46*	-0.41*	-1.09*	-0.71*	-0.68*	-	-	-	-	-
Free Cashflow	-	-	-	-100	99.00	83.00	82.00	-97.48	44.00	61.00	54.00	-82.19	-11.87	170	188	-141	135	-	-	-	-	-

Balance Sheet
(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Assets	0.9%	2,326	2,306	2,320	2,348	2,332	2,370	2,341	2,723	2,646	2,555	2,484	3,348	3,425	3,387	4,320	4,146	4,291	5,639	5,706	5,937	5,839
Current Assets	5.7%	421	398	409	428	424	459	440	841	788	752	665	1,549	1,651	688	941	732	965	986	1,057	660	625
Cash Equivalents	262.1%	21.00	6.00	6.00	10.00	9.00	14.00	7.00	387	358	338	270	1,124	295	132	312	108	25.00	36.00	46.00	41.00	42.00
Net PPE	2.5%	75.00	73.00	73.00	73.00	72.00	72.00	72.00	70.00	73.00	68.00	81.00	76.00	79.00	98.00	100	73.00	94.00	93.00	89.00	90.00	138
Goodwill	0%	1,532	1,532	1,532	1,532	1,532	1,532	1,529	1,510	1,497	1,487	1,482	1,480	1,481	2,165	2,710	1,480	2,635	4,070	4,066	4,061	4,303
Liabilities	-0.4%	1,358	1,363	1,410	1,456	1,473	1,524	1,464	1,826	1,800	1,746	1,717	2,600	2,620	2,561	2,832	2,647	2,811	2,914	2,926	2,850	2,823
Current Liabilities	9.4%	350	320	284	427	352	329	270	427	398	351	327	444	488	384	346	542	501	441	415	503	436
Long Term Debt	-0.6%	622	625	-	632	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Shareholder's Equity	2.7%	968	942	910	892	859	845	877	897	846	809	767	748	805	827	1,487	1,499	1,479	2,725	2,780	3,088	3,015
Retained Earnings	45.9%	-25.18	-46.57	-74.86	-89.06	-118	-149	-176	-155	-202	-233	-268	-286	-222	-179	491	510	501	1,757	1,801	2,094	2,016
Additional Paid-In Capital	0.4%	996	992	987	984	981	997	1,054	1,050	1,045	1,039	1,032	1,029	1,024	1,005	995	988	978	967	978	993	999
Shares Outstanding	0.1%	84.00	84.00	84.00	83.00	83.00	85.00	85.00	86.00	85.00	85.00	85.00	86.00	84.00	83.00	83.00	84.00	82.00	83.00	86.00	88.00	91.00
Minority Interest	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-	-	-	-	-

Cashflow (Last 12 Months)
(In Millions)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Cashflow From Operations	-10.2%	79,938	89,054	-100,917	98,686	83,330	82,407	-97,482	44,236	61,102	53,587	-82,188	-11,866	169,935	188,435	-141,884	135,297	159,199	120,032	-56,817	151,377	140,727
Share Based Compensation	1.2%	3,164	3,126	3,009	3,236	4,120	4,336	4,435	4,021	5,495	5,735	3,717	2,922	22,946	5,731	7,443	5,898	6,659	9,864	10,989	7,835	8,742
Cashflow From Investing	-34.7%	-14,004	-10,398	-11,350	-11,241	-6,088	-13,352	-26,273	-15,584	-41,214	14,089	-10,364	840,611	-3,441	-1,439	-20,220	156,977	-26,888	-18,943	-8,691	-94,989	-8,806
Cashflow From Financing	35.9%	-50,604	-78,931	108,567	-86,289	-82,662	-62,146	-256,457	825	-131	851	-761,661	586	-4,133	-366,650	366,039	-209,499	-143,150	-107,085	66,664	-30,321	-135,515
Buy Backs	1109.1%	133	11.00	775	1,480	21,477	64,398	1,166	-	2,474	251	1,994	-2.00	5,452	501	2,542	356	415	65,527	78,982	-	250,000

MD Income Statement

2023-09-30

Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Net revenue	$ 506,612	$ 489,915	$ 1,498,197	$ 1,458,177
Operating expenses:
Practice salaries and benefits	368,404	342,850	1,084,671	1,016,762
Practice supplies and other operating expenses	31,319	31,857	93,128	90,189
General and administrative expenses	57,406	57,888	174,478	180,340
Depreciation and amortization	9,211	8,956	27,109	26,500
Transformational and restructuring related expenses	0	977	0	7,736
Total operating expenses	466,340	442,528	1,379,386	1,321,527
Income from operations	40,272	47,387	118,811	136,650
Investment and other income	273	617	2,096	2,336
Interest expense	(10,374)	(9,516)	(31,994)	(29,743)
Loss on early extinguishment of debt	0	0	0	(57,016)
Equity in earnings of unconsolidated affiliate	661	371	1,578	1,319
Total non-operating expenses	(9,440)	(8,528)	(28,320)	(83,104)
Income from continuing operations before income taxes	30,832	38,859	90,491	53,546
Income tax provision	(9,441)	(10,051)	(26,612)	(14,982)
Income from continuing operations	21,391	28,808	63,879	38,564
Income (loss) from discontinued operations, net of tax	0	1,920	0	(1,892)
Net income	21,391	30,728	63,879	36,672
Net loss attributable to noncontrolling interest	0	0	0	4
Net income attributable to Pediatrix Medical Group, Inc.	21,391	30,728	63,879	36,676
Other comprehensive (loss) income, net of tax	1	(1,515)	218	(5,417)
Total comprehensive income attributable to Pediatrix Medical Group, Inc.	$ 21,392	$ 29,213	$ 64,097	$ 31,259
Net income attributable to Pediatrix Medical Group, Inc.:
Basic	$ 0.26	$ 0.37	$ 0.78	$ 0.44
Diluted	$ 0.26	$ 0.37	$ 0.77	$ 0.43
Weighted average common shares:
Basic	82,543	82,126	82,127	84,122
Diluted	82,950	82,776	82,492	84,821

MD Balance Sheet

2023-09-30

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 21,179	$ 9,824
Short-term investments	103,541	93,239
Accounts receivable, net	277,352	296,787
Prepaid expenses	10,586	14,878
Other current assets	7,866	13,261
Total current assets	420,524	427,989
Property and equipment, net	75,146	73,290
Goodwill	1,532,092	1,532,092
Intangible assets, net	15,486	18,491
Operating and finance lease right-of-use assets	72,443	66,924
Deferred income tax assets	102,638	105,925
Other assets	108,010	123,176
Total assets	2,326,339	2,347,887
Current liabilities:
Accounts payable and accrued expenses	302,583	374,225
Current portion of debt and finance lease liabilities, net	14,929	14,898
Current portion of operating lease liabilities	21,814	21,589
Income taxes payable	11,118	16,271
Total current liabilities	350,444	426,983
Line of credit	0	4,000
Long-term debt and finance lease liabilities, net	621,691	632,381
Long-term operating lease liabilities	48,489	44,213
Long-term professional liabilities	265,523	275,629
Deferred income tax liabilities	41,018	33,638
Other liabilities	31,189	39,411
Total liabilities	1,358,354	1,456,255
Commitments and contingencies
Shareholders' equity:
Preferred stock; $.01 par value; 1,000 shares authorized; none issued	0	0
Common stock; $.01 par value; 200,000 shares authorized; 83,929 and 82,947 shares issued and outstanding, respectively	839	829
Additional paid-in capital	995,847	983,601
Accumulated other comprehensive loss	(3,517)	(3,735)
Retained deficit	(25,184)	(89,063)
Total shareholders' equity	967,985	891,632
Total liabilities and shareholders' equity	$ 2,326,339	$ 2,347,887

About MEDNAX Inc

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

CEO	Dr. James D. Swift M.D.
WEBSITE	www.pediatrix.com
EMPLOYEES	5250

MEDNAX Inc Frequently Asked Questions

What is the ticker symbol for MEDNAX Inc? What does MD stand for in stocks?

MD is the stock ticker symbol of MEDNAX Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of MEDNAX Inc (MD)?

As of Thu Dec 07 2023, market cap of MEDNAX Inc is 783.06 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MD stock?

You can check MD's fair value in chart. The fair value of MEDNAX Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of MEDNAX Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for MD so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is MEDNAX Inc a good stock to buy?

The fair value guage provides a quick view whether MD is over valued or under valued. Whether MEDNAX Inc is cheap or expensive depends on the assumptions which impact MEDNAX Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MD.

What is MEDNAX Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Dec 07 2023, MD's PE ratio (Price to Earnings) is 8.37 and Price to Sales (PS) ratio is 0.39. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MD PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on MEDNAX Inc's stock?

In the past 10 years, MEDNAX Inc has provided -0.164 (multiply by 100 for percentage) rate of return.

Market Summary

MD Stock Price

MD RSI Chart

MD Valuation

MD Price/Sales (Trailing)

MD Profitability

MD Fundamentals

MD Revenue

MD Earnings

Price Action

How does MD drawdown profile look like?

MD Financial Health

MD Investor Care

Historical Charts for Stock Metrics

Latest Insider Trading transactions for MD

Which funds bought or sold MD recently?

Latest Funds Activity

Schedule 13G FIlings of MEDNAX Inc

Recent SEC filings of MEDNAX Inc

MD Fair Value

Peers (Alternatives to MEDNAX Inc)

MEDNAX Inc News

Financials for MEDNAX Inc

Income Statement (Last 12 Months).css-zgnqz2{margin:0;font-family:"Roboto","Helvetica","Arial",sans-serif;font-weight:400;font-size:0.75rem;line-height:1.66;letter-spacing:0.03333em;color:#595959;}(In Millions)

Balance Sheet(In Millions)

Cashflow (Last 12 Months)(In Millions)

MD Income Statement

MD Balance Sheet

About MEDNAX Inc

MEDNAX Inc Frequently Asked Questions

What is the ticker symbol for MEDNAX Inc? What does MD stand for in stocks?

What is the market capital of MEDNAX Inc (MD)?

What is the fair value of MD stock?

Is MEDNAX Inc a good stock to buy?

What is MEDNAX Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

What is 5 year return on MEDNAX Inc's stock?

Income Statement (Last 12 Months)
(In Millions)

Balance Sheet
(In Millions)

Cashflow (Last 12 Months)
(In Millions)